Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography

Based on the observation of bilateral temporoparietal hypoperfusion in Alzheimer's disease (AD), single photon emission computed tomography (SPECT) is advocated by some as a powerful diagnostic tool in the evaluation of demented patients. We studied whether routine brain SPECT in elderly, mildly demented outpatients increases the a priori diagnostic sensitivity and specificity of a careful clinical examination.99mTc-HMPAO SPECT imaging was performed in 110 patients for a first evaluation for dementia. A semiquantitative measure of temporoparietal (TP) perfusion was calculated as the ratio of the activity in the temporoparietal cortex to activity in the cerebellum. A diagnosis of probable AD according to the McKhann criteria was made in 68 patients (mean age of 79.3 years) based on the results of a clinical examination, ancillary investigations and a 6-month follow-up. TP perfusion was significantly lower in AD patients than in 18 age-matched, non-demented controls. However, at a specificity of 89%, sensitivity was only 43% for detecting probable AD. The clinicians judged that SPECT had contributed to the final diagnosis in only 8% of the demented patients investigated. Routine brain SPECT in elderly, mildly demented outpatients does not contribute substantially to diagnostic accuracy after a careful clinical examination using current diagnostic criteria. Clinical guidelines have to be developed for the use of SPECT in patients with (suspected) dementia.

[1]  S. Eagger,et al.  Patterns of regional cerebral blood flow in Alzheimer's disease. , 1992, Nuclear medicine communications.

[2]  B L Holman,et al.  The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  T. Fukumura,et al.  Differential Diagnosis of Bilateral Parietal Abnormalities in I-123 IMP SPECT Imaging , 1990, Clinical nuclear medicine.

[4]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[5]  M. Abou-Saleh,et al.  A Study of Depression in Old Age Using Single-Photon Emission Computerised Tomography , 1990, British Journal of Psychiatry.

[6]  E. Pauwels,et al.  SPECT in the diagnosis of Alzheimer's disease and multi-infarct-dementia , 1991, Clinical Neurology and Neurosurgery.

[7]  W. Ammann,et al.  Single Photon Emission Computed Tomography Using 99mTc-HM-PAO in the Routine Evaluation of Alzheimer's Disease , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[8]  F. Huppert,et al.  CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.

[9]  Keith A. Johnson,et al.  Cerebral perfusion imaging in Alzheimer??s disease: use of single photon emission computed tomography and iofetamine hydrochloride I 123 , 1987 .

[10]  H. Hanyu,et al.  [Neuroimaging in the diagnosis of Alzheimer's disease]. , 1994, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[11]  E. Metter,et al.  Diagnosis of Alzheimer's disease and multiple infarct dementia by tomographic imaging of iodine-123 IMP. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  T. Erkinjuntti,et al.  99Tcm-HMPAO SPECT in suspected dementia , 1991, Nuclear medicine communications.

[13]  W. Jagust,et al.  The diagnosis of dementia with single photon emission computed tomography. , 1987, Archives of neurology.

[14]  G. Walstra,et al.  [CAMDEX-N: the Dutch version of the Cambridge Examination for Mental Disorders of the Elderly with automatic data processing]. , 1991, Tijdschrift voor gerontologie en geriatrie.

[15]  T. Videen,et al.  Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease , 1992, Neurology.

[16]  D. Neary,et al.  Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[17]  P Gerundini,et al.  Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  E. V. van Royen,et al.  Single photon emission computed tomography in Alzheimer's disease. , 1989, Archives of neurology.

[19]  P. Marièn,et al.  Tc-99m HMPAO brain SPECT in dementia due to transitory obstructive hydrocephalus. , 1993, Clinical nuclear medicine.

[20]  J. Fuh,et al.  Single photon emission computed tomography using 99Tcm-HMPAO in Alzheimer's disease. , 1992, Nuclear medicine communications.

[21]  Diagnosis of Alzheimer's disease. , 1991, BMJ.

[22]  J. Lindeboom,et al.  Are age and education independent correlates of the Mini-Mental State Exam performance of community-dwelling elderly? , 1993, Journal of gerontology.

[23]  M. Devous,et al.  Functional brain SPECT: the emergence of a powerful clinical method. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  J. Growdon,et al.  Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity. , 1988, Archives of neurology.

[25]  A. Bockisch,et al.  HMPAO-SPECT imaging resembling Alzheimer-type dementia in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  D W Palmer,et al.  Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging. , 1989, Radiology.

[27]  B. Holman,et al.  Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. , 1987, Archives of neurology.

[28]  E. P. Krenning,et al.  The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease , 1994, Neurology.

[29]  P. Scheltens,et al.  Neuro-imaging in the diagnosis of Alzheimer's disease II. Positron and single photon emission tomography , 1993, Clinical Neurology and Neurosurgery.

[30]  P. Sharp,et al.  The use of 99Tcm-HM-PAO for the diagnosis of dementia. , 1987, Nuclear medicine communications.

[31]  M. Mendez,et al.  Clinically Diagnosed Alzheimer Disease: Neuropathologic Findings in 650 Cases , 1992, Alzheimer disease and associated disorders.

[32]  D Wyper,et al.  Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.